The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 04, 2022

Filed:

Mar. 23, 2017
Applicants:

The Broad Institute, Inc., Cambridge, MA (US);

Massachusetts Institute of Technology, Cambridge, MA (US);

Inventors:

Randall Jeffrey Platt, Basel, CH;

Feng Zhang, Cambridge, MA (US);

Ian Slaymaker, Cambridge, MA (US);

Assignees:

The Broad Institute, Inc., Cambridge, MA (US);

Massachusetts Institute of Technology, Cambridge, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/10 (2006.01); C12N 15/63 (2006.01); C12N 9/22 (2006.01); A01K 67/027 (2006.01); C12N 15/11 (2006.01); C12N 15/85 (2006.01); C12N 15/86 (2006.01); C12N 15/90 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1024 (2013.01); A01K 67/0275 (2013.01); C12N 9/22 (2013.01); C12N 15/1082 (2013.01); C12N 15/111 (2013.01); C12N 15/63 (2013.01); C12N 15/8509 (2013.01); C12N 15/86 (2013.01); C12N 15/907 (2013.01); A01K 2217/072 (2013.01); A01K 2227/105 (2013.01); A01K 2267/0306 (2013.01); A01K 2267/0318 (2013.01); C12N 2015/8536 (2013.01); C12N 2310/10 (2013.01); C12N 2310/20 (2017.05); C12N 2310/3519 (2013.01); C12N 2310/531 (2013.01); C12N 2320/11 (2013.01); C12N 2320/32 (2013.01); C12N 2330/51 (2013.01); C12N 2740/16043 (2013.01); C12N 2750/14143 (2013.01); C12N 2830/008 (2013.01);
Abstract

Methods and compositions for inducing a plurality of mutations in transgenic Cas9 eukaryotes to model a neuronal disease or disorder. The invention further comprehends testing putative treatments with such models, e.g., testing putative chemical compounds that may be pharmaceutically relevant for treatment or gene therapy that may be relevant for treatment, or combinations thereof. The invention allows for the study of genetic diseases and putative treatments to better understand and alleviate a genetic disease or a condition, e.g., autism, autism-spectrum disease or disorder, obsessive-compulsive disorder, or psychiatric disorders.


Find Patent Forward Citations

Loading…